المؤلفون: Shangguan W; School of Pharmacy, Fudan University, 201203 Shanghai, China.; Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 201203 Shanghai, China., Li X; School of Pharmacy, Fudan University, 201203 Shanghai, China.; Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 201203 Shanghai, China., Wang Y; Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 201203 Shanghai, China.; Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, 310014 Hangzhou, China., Huang Z; Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 201203 Shanghai, China.; Shanghai Duomirui Biotechnology Co Ltd, 201203 Shanghai, China., Dong Y; Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 201203 Shanghai, China.; Shanghai Duomirui Biotechnology Co Ltd, 201203 Shanghai, China., Feng M; School of Pharmacy, Fudan University, 201203 Shanghai, China., Feng J; Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 201203 Shanghai, China.

المصدر: Bioconjugate chemistry [Bioconjug Chem] 2024 May 15; Vol. 35 (5), pp. 653-664. Date of Electronic Publication: 2024 Apr 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9010319 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4812 (Electronic) Linking ISSN: 10431802 NLM ISO Abbreviation: Bioconjug Chem Subsets: MEDLINE

مواضيع طبية MeSH: Fatty Acids*/chemistry , Ornithodoros* , Complement C5*/antagonists & inhibitors, Animals ; Mice ; Drug Design ; Half-Life ; Complement Inactivator Proteins/pharmacology ; Complement Inactivator Proteins/chemistry ; Complement Inactivating Agents/pharmacology ; Complement Inactivating Agents/pharmacokinetics ; Complement Inactivating Agents/chemistry ; Humans

المؤلفون: Garg A; Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada., Nanji K; Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Tai F; Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada., Phillips M; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Zeraatkar D; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Garg SJ; Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USA., Sadda SR; Department of Ophthalmology, David Geffen School of Medicine at University of California, Los Angeles, CA, USA; Doheny Eye Institute, Los Angeles, CA, USA., Kaiser PK; Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA., Guymer RH; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia; Department of Surgery (Ophthalmology), University of Melbourne, Melbourne, Australia., Sivaprasad S; Institute of Ophthalmology, University College London, UK; NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK., Wykoff CC; Retina Consultants of Texas, Houston, TX, USA; Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA., Chaudhary V; Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada. Electronic address: vchaudh@mcmaster.ca.

المصدر: Survey of ophthalmology [Surv Ophthalmol] 2024 May-Jun; Vol. 69 (3), pp. 349-361. Date of Electronic Publication: 2023 Nov 24.

نوع المنشور: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0404551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3304 (Electronic) Linking ISSN: 00396257 NLM ISO Abbreviation: Surv Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Complement C3*/metabolism , Complement C3*/antagonists & inhibitors , Complement C5*/antagonists & inhibitors , Complement Inactivating Agents*/therapeutic use , Geographic Atrophy*/drug therapy , Geographic Atrophy*/diagnosis , Geographic Atrophy*/etiology , Geographic Atrophy*/physiopathology, Humans ; Macular Degeneration/drug therapy ; Visual Acuity

المصدر: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2024 Apr 15; Vol. 66 (1700), pp. 60-62.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN: 1523-2859 (Electronic) Linking ISSN: 0025732X NLM ISO Abbreviation: Med Lett Drugs Ther Subsets: MEDLINE

مواضيع طبية MeSH: Myasthenia Gravis*/diagnosis , Myasthenia Gravis*/drug therapy , Complement C5* , Peptides, Cyclic*, Humans ; Immunosuppressive Agents

المؤلفون: Kulasekararaj AG; King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK and King's College London, London., Lehtinen AE; Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki., Forsyth C; Gosford Hospital, Gosford, NSW., Gandhi S; King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK and King's College London, London., Griffin M; St. James's University Hospital, Leeds., Körper S; University of Ulm, Institute of Transfusion Medicine, and Institute of Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm., Mikala G; Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Budapest., Muus P; King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK and King's College London, London, UK; St. James's University Hospital, Leeds., Overgaard U; University Hospital Copenhagen, Copenhagen, Denmark., Patriquin CJ; University Health Network, Toronto, ON., Pullon H; Waikato Hospital, Hamilton., Shen YM; UT Southwestern Medical Center, Dallas, TX., Spearing R; Christchurch Hospital, Christchurch., Szer J; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC., De la Borderie G; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC., Duda PW; UCB Pharma, Cambridge, MA., Farzaneh-Far R; UCB Pharma, Cambridge, MA., Ragunathan S; UCB Pharma, Cambridge, MA., Sayegh CE; UCB Pharma, Cambridge, MA., Vadysirisack DD; UCB Pharma, Cambridge, MA., Schrezenmeier H; University of Ulm, Institute of Transfusion Medicine, and Institute of Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm. h.schrezenmeier@blutspende.de.

المصدر: Haematologica [Haematologica] 2024 Mar 01; Vol. 109 (3), pp. 929-935. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Clinical Trial, Phase II; Letter

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Complement C5*/therapeutic use , Hemoglobinuria, Paroxysmal*/drug therapy , Peptides, Cyclic*/therapeutic use, Humans

المؤلفون: Jindal S; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Pedersen DV; Department of Molecular Biology and Genetics, Universitetsbyen 83, Aarhus University, Aarhus, Denmark., Gera N; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Chandler J; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Patel R; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Neill A; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Cone J; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Zhang Y; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Yuan CX; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Millman EE; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Carlin D; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA. Electronic address: Dan.Carlin@alexion.com., Puffer B; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Sheridan D; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Andersen GR; Department of Molecular Biology and Genetics, Universitetsbyen 83, Aarhus University, Aarhus, Denmark., Tamburini P; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA.

المصدر: Molecular immunology [Mol Immunol] 2024 Jan; Vol. 165, pp. 29-41. Date of Electronic Publication: 2023 Dec 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 7905289 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9142 (Electronic) Linking ISSN: 01615890 NLM ISO Abbreviation: Mol Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Complement C5* , Single-Domain Antibodies*, Humans ; Complement System Proteins/metabolism ; Complement Activation ; Albumins

المؤلفون: Liu A; Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases, The Eighth Affiliated Hospital of Sun Yat-sen University, Shennan Middle Rd, Shenzhen, 518000, China., Chen Z; Department of Nephrology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, 518000, China., Li X; Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases, The Eighth Affiliated Hospital of Sun Yat-sen University, Shennan Middle Rd, Shenzhen, 518000, China., Xie C; Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases, The Eighth Affiliated Hospital of Sun Yat-sen University, Shennan Middle Rd, Shenzhen, 518000, China., Chen Y; Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases, The Eighth Affiliated Hospital of Sun Yat-sen University, Shennan Middle Rd, Shenzhen, 518000, China., Su X; Department of Nephropathy, Tungwah Hospital of Sun Yat-Sen University, Dongguan, 523000, China., Chen Y; Department of Nephropathy, Tungwah Hospital of Sun Yat-Sen University, Dongguan, 523000, China., Zhang M; Department of Nephropathy, Tungwah Hospital of Sun Yat-Sen University, Dongguan, 523000, China., Chen J; Department of Radiotherapy, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, 510000, China., Yang T; Department of Nephrology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, 518000, China., Shen J; School of Chinese Medicine, Li Ka Shing Faculty of Medicine, State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, 999077, China., Huang H; Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases, The Eighth Affiliated Hospital of Sun Yat-sen University, Shennan Middle Rd, Shenzhen, 518000, China.

المصدر: Cardiovascular research [Cardiovasc Res] 2023 Nov 25; Vol. 119 (15), pp. 2563-2578.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print Cited Medium: Internet ISSN: 1755-3245 (Electronic) Linking ISSN: 00086363 NLM ISO Abbreviation: Cardiovasc Res Subsets: MEDLINE

مواضيع طبية MeSH: Cardiovascular Diseases* , Endoplasmic Reticulum Stress* , Vascular Calcification*/pathology , Complement C5*/metabolism, Animals ; Mice ; Calcium ; Cross-Sectional Studies ; Eukaryotic Initiation Factor-2/metabolism ; Eukaryotic Initiation Factor-2/pharmacology ; Signal Transduction

المؤلفون: Struijf EM; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., De la O Becerra KI; Structural Biochemistry Group, Faculty of Science, Department of Chemistry, Bijvoet Centre for Biomolecular Research, Utrecht University, Utrecht, The Netherlands., Ruyken M; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., de Haas CJC; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Oosterom F; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Siere DY; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Keulen JE; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Heesterbeek DAC; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Dolk E; QVQ Holding BV, Utrecht, The Netherlands., Heukers R; QVQ Holding BV, Utrecht, The Netherlands., Bardoel BW; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Gros P; Structural Biochemistry Group, Faculty of Science, Department of Chemistry, Bijvoet Centre for Biomolecular Research, Utrecht University, Utrecht, The Netherlands., Rooijakkers SHM; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Electronic address: s.h.m.rooijakkers@umcutrecht.nl.

المصدر: The Journal of biological chemistry [J Biol Chem] 2023 Aug; Vol. 299 (8), pp. 104956. Date of Electronic Publication: 2023 Jun 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal* , Complement C5*/antagonists & inhibitors , Complement C5*/genetics , Single-Domain Antibodies*, Humans ; Complement Activation ; Complement Membrane Attack Complex ; Complement System Proteins/metabolism

المؤلفون: Tang GQ; UCB Pharma, Cambridge, MA, United States., Tang Y; UCB Pharma, Cambridge, MA, United States., Dhamnaskar K; Ra Pharmaceuticals, Cambridge, MA, United States., Hoarty MD; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States., Vyasamneni R; Ra Pharmaceuticals, Cambridge, MA, United States., Vadysirisack DD; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States., Ma Z; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States., Zhu N; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States., Wang JG; UCB Pharma, Cambridge, MA, United States., Bu C; UCB Pharma, Cambridge, MA, United States., Cong B; UCB Pharma, Cambridge, MA, United States., Palmer E; UCB Pharma, Cambridge, MA, United States., Duda PW; UCB Pharma, Cambridge, MA, United States., Sayegh C; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States., Ricardo A; Ra Pharmaceuticals, Cambridge, MA, United States.

المصدر: Frontiers in immunology [Front Immunol] 2023 Aug 09; Vol. 14, pp. 1213920. Date of Electronic Publication: 2023 Aug 09 (Print Publication: 2023).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Complement Activation* , Complement C5*/antagonists & inhibitors , Hemolysis*, Humans ; Antibodies, Monoclonal

المؤلفون: Nelke C; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Schroeter CB; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Stascheit F; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Neuroscience Clinical Research Center, Berlin, Germany., Huntemann N; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Pawlitzki M; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Willison A; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Räuber S; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Melzer N; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Distler U; University Medical Center of the Johannes-Gutenberg University Mainz, Mainz, Germany., Tenzer S; University Medical Center of the Johannes-Gutenberg University Mainz, Mainz, Germany.; Helmholtz Institute for Translational Oncology (HI-TRON) Mainz, Germany.; Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany., Stühler K; Molecular Proteomics Laboratory, Heinrich Heine University, Düsseldorf, Germany., Roos A; Department of Neuropediatrics, University of Duisburg-Essen, Essen, Germany., Meisel A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Neuroscience Clinical Research Center, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Center for Stroke Research Berlin, Berlin, Germany., Meuth SG; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Ruck T; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

المصدر: JCI insight [JCI Insight] 2023 Jul 10; Vol. 8 (13). Date of Electronic Publication: 2023 Jul 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE

مواضيع طبية MeSH: Complement C5* , Myasthenia Gravis*/drug therapy, Humans ; Complement System Proteins ; Complement Activation ; Receptor, Anaphylatoxin C5a ; Leukotrienes

المؤلفون: Makkawi S; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; Department of Neurosciences, Ministry of The National Guard-Health Affairs, Jeddah, Saudi Arabia. Electronic address: serajmakkawi@gmail.com., Salamatullah HK; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Alkhiri A; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Faidah DE; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Afif LM; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Bukhari JI; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Abulaban A; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Neurology Division, Department of Medicine, Ministry of The National Guard-Health Affairs, Riyadh, Saudi Arabia., Al Malik Y; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Neurology Division, Department of Medicine, Ministry of The National Guard-Health Affairs, Riyadh, Saudi Arabia., Levy M; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

المصدر: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 May; Vol. 85, pp. 105524. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Systematic Review; Meta-Analysis; Journal Article; Review

بيانات الدورية: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

مواضيع طبية MeSH: Neuromyelitis Optica*/drug therapy , Neuromyelitis Optica*/immunology , Aquaporin 4*/immunology , Aquaporin 4*/antagonists & inhibitors , Autoantibodies*/blood, Humans ; Complement C5/antagonists & inhibitors ; Complement C5/immunology ; Randomized Controlled Trials as Topic